Training program for postdoctoral fellows in tumor immunotherapy and immunology
Official title: UNC Immunotherapy Training Grant (IM-TAG)
Funded at Univ of North Carolina Chapel Hill · NIH-10930107 · Data updated 2026-11-12
This program at the University of North Carolina is helping new scientists learn about exciting ways to use the immune system to fight cancer, like developing vaccines and new therapies, so they can become experts and help improve treatments for patients.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $181,622 |
| NIH project number | 5T32CA285257-02 |
| Project ID | NIH-10930107 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be postdoctoral fellows interested in advancing their careers in tumor immunology and immunotherapy.
✕Less likely to help
Patients who are not postdoctoral fellows or those not involved in academic research may not receive direct benefits from this program.
What this research studies
This program at the University of North Carolina at Chapel Hill trains postdoctoral fellows in the fields of tumor immunotherapy, tumor immunology, and stem cell transplantation immunology. The training involves mentorship from leading experts and focuses on innovative approaches such as vaccine design, adoptive cellular therapy, and understanding immune responses in the tumor microenvironment. Participants will engage in both basic and translational research, contributing to advancements in immune-based therapies. The program aims to address the shortage of trained investigators in these critical areas of cancer treatment.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy strategies that enhance patient outcomes in cancer treatment.
How similar studies have gone: Previous training programs in immunotherapy have shown success in developing skilled researchers who contribute to significant advancements in cancer treatment.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Serody, Jonathan S. — Univ of North Carolina Chapel Hill
- Study coordinator: Serody, Jonathan S.
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
How CRISPR-based gene activation could shape immunotherapy responses in clear cell cancers
A research project at Stanford is using CRISPR-based gene activation to understand why some clear cell ovarian and kidney cancers respond to immunotherapy while others do not.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.